BEGIN:VCALENDAR
VERSION:2.0
CALSCALE:GREGORIAN
PRODID:iCalendar-Ruby
BEGIN:VEVENT
SEQUENCE:0
CONTACT:biz@aptn.org
ORGANIZER:Asia-Pacific Technology Network in association with Olswang\, the
  London Biotechnology Networkand the R&D Society
DTEND:20080507T203000
DTSTART:20080507T181500
UID:2009-11-09T18:15:18-05:00_628450914@socialweb1
DTSTAMP:20091109T181518
DESCRIPTION:Spurred on by global ambitions of its top players\, formidable 
 core competencies and an evolving global marketplace\, the Indian pharmaceu
 tical industry is perhaps at inflection point towards a phase of high value
  growth with increasing international revenues and the emergence of innovat
 ive business models. Dr Brian Tempest - former Chief Mentor and Executive V
 ice Chairman of Ranbaxy Laboratories is particularly well placed to draw on
  his experiences both at Ranbaxy - one of the world's largest generic pharm
 aceutical companies and within global pharmaceutical leadership roles over 
 37 years\, to discuss what future leading Indian pharmaceutical companies w
 ill look like\, and what opportunities this presents for UK R&D.
\n
\nProfe
 ssor Barry Furr\, former Chief Scientific Officer at Astra Zeneca\, well ve
 rsed with pharmaceutical R&D across the world including notably Astra Zenec
 a's Tuberculosis Research Center in Bangalore will moderate the discussion 
 raising pertinent questions. This event will be a unique opportunity to lea
 rn the views of two experienced industry veterans about a group of companie
 s that could well shake up the global industry.
SUMMARY:India's Pharmaceutical Industry: The Journey Ahead
LAST-MODIFIED:20080430T130504
CREATED:20080419T193353
END:VEVENT
END:VCALENDAR